In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Adverum Biotechnologies Inc (NASDAQ: ADVM) closed at $2.32 in the last session, down -6.83% from day before closing price of $2.49. In other words, the price has decreased by -$6.83 from its previous closing price. On the day, 2.79 million shares were traded. ADVM stock price reached its highest trading level at $2.56 during the session, while it also had its lowest trading level at $2.27.
Ratios:
We take a closer look at ADVM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.57 and its Current Ratio is at 3.57. In the meantime, Its Debt-to-Equity ratio is 3.53 whereas as Long-Term Debt/Eq ratio is at 3.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on June 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $25.
On April 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.
Truist Upgraded its Hold to Buy on July 07, 2022, while the target price for the stock was maintained at $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when Soparkar Peter sold 2,960 shares for $2.00 per share. The transaction valued at 5,920 led to the insider holds 39,154 shares of the business.
Seyedkazemi Setareh sold 924 shares of ADVM for $1,848 on May 15 ’25. The CHIEF DEVELOPMENT OFFICER now owns 13,768 shares after completing the transaction at $2.00 per share. On May 15 ’25, another insider, Fischer Laurent, who serves as the CEO, PRESIDENT AND DIRECTOR of the company, sold 9,126 shares for $2.00 each. As a result, the insider received 18,252 and left with 87,488 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADVM now has a Market Capitalization of 48466424 and an Enterprise Value of 58561500. For the stock, the TTM Price-to-Sale (P/S) ratio is 48.47 while its Price-to-Book (P/B) ratio in mrq is 1.83. Its current Enterprise Value per Revenue stands at 58.562 whereas that against EBITDA is -0.378.
Stock Price History:
The Beta on a monthly basis for ADVM is 0.73, which has changed by -0.6671449 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, ADVM has reached a high of $10.14, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is -11.69%, while the 200-Day Moving Average is calculated to be -52.58%.
Shares Statistics:
According to the various share statistics, ADVM traded on average about 344.80K shares per day over the past 3-months and 472530 shares per day over the past 10 days. A total of 20.89M shares are outstanding, with a floating share count of 13.83M. Insiders hold about 33.78% of the company’s shares, while institutions hold 58.54% stake in the company. Shares short for ADVM as of 1749772800 were 1843405 with a Short Ratio of 5.35, compared to 1747267200 on 1584676. Therefore, it implies a Short% of Shares Outstanding of 1843405 and a Short% of Float of 10.07.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
